About the partnership
The purpose of this partnership between Karolinska Institutet and MSD is to jointly identify and perform research in the areas of patient inspired innovation, and real-world evidence methodologies. The aim is to use patient-centered research and real-world data to produce meaningful evidence that enables better healthcare decisions, improves patient outcomes, and drives greater value in healthcare delivery.
The collaboration between KI and MSD mainly covers the focus areas of:
A joint steering group decides advises which projects are to be included and which clinical studies can may be considered. The agreement sets the framework for a close collaboration in which researchers from both sides work together without imposing any limits on the scope of the research in advance. Investment decisions for the remainder of the collaboration will be taken continuously by a steering group comprising representatives from KI and MSD. The steering group is advisory, reviewing quality and improve ideas put forward.
The collaboration encompasses two broad activity arms: Analytic and methodological research – focused on advanced real-world data analytics, predictive modeling and development of new methodology & Registry-based research – identification and development of robust real-world data sets for innovative research.
Karolinska Institutet and MSD are interested in exploring Real-world data analytic and methodology research Karolinska and MSD are interested in exploring novel methods e.g. modeling, predictive modeling, informatics, natural language processing, machine learning, artificial intelligence as well as other advanced analytic methods focused on generating insights and scientific evidence from real-world data to enhance product development and identify/quantify the clinical and economic value throughout product lifecycle.
Karolinska Institutet and MSD intend to collaborate in joint focus areas to produce robust and relevant real-life data utilizing the Swedish health and disease-specific registries. The Steering group would evaluate and approve support the strategy and overall program plan to fund specific studies and projects for a given registry. Disease Areas of interest include, but are not limited to: oncology, vaccine, neuroscience, diabetes, and cardiovascular.